Conference
A phase II trial of perifosine as second line therapy for advanced pancreatic cancer. A study of the Princess Margaret Hospital [PMH] phase II consortium.
Authors
Hedley D; Moore MJ; Hirte H; Siu L; Vincent M; Jonker D; Mwang H; Nagai J; Dancey J
Volume
23
Pagination
pp. 349S-349S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 1, 2005
Name of conference
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
FL, Orlando
Conference start date
May 13, 2005
Conference end date
May 17, 2005
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X